ISS-1018

N/A

Report date: 2026/02/13 20:01:31

Base Information

Drug NameISS-1018
Drug Alias NameISS1ISS2ISS-10181018-ISSISS-DNA
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsColorectal NeoplasmsLymphoma, Non-HodgkinHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDynavax GmbhDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDana-Farber Cancer InstituteDynavax Technologies Corp
Active IndicationsN/A
Inactive IndicationsColorectal NeoplasmsLymphoma, Non-HodgkinHepatitis B

Other Information

ATC CodeN/A
Related LinksDrugBank